24 C
February 24, 2024
The Hona News

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very poor prognosis. But clinical studies have shown that drugs called FLT3 inhibitors can extend long-term survival in these patients, especially when given in combination with other treatments.

Source link

Related posts

Mortality, morbidity increased with heart failure hospitalization in adults with congenital heart disease


Cycling to work linked with better mental health


Understanding the neuroendocrine basis for social anxiety–like behavior in male mice


Leave a Comment